vs
Side-by-side financial comparison of Idaho Strategic Resources, Inc. (IDR) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.
Idaho Strategic Resources, Inc. is the larger business by last-quarter revenue ($14.6M vs $8.6M, roughly 1.7× Sunshine Biopharma Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -25.0%, a 89.2% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs -10.6%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $-1.6M). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs 6.6%).
Idaho Strategic Resources, Inc.IDREarnings & Financial Report
Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
IDR vs SBFM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.6M | $8.6M |
| Net Profit | $9.4M | $-2.1M |
| Gross Margin | 68.5% | 35.3% |
| Operating Margin | 62.4% | -20.9% |
| Net Margin | 64.3% | -25.0% |
| Revenue YoY | 92.0% | -10.6% |
| Net Profit YoY | 220.6% | 0.8% |
| EPS (diluted) | $0.62 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.6M | $8.6M | ||
| Q3 25 | $11.1M | $9.4M | ||
| Q2 25 | $9.5M | $9.4M | ||
| Q1 25 | $7.3M | $8.9M | ||
| Q4 24 | $7.6M | $9.6M | ||
| Q3 24 | $6.2M | $8.4M | ||
| Q2 24 | $6.1M | $9.3M | ||
| Q1 24 | $5.9M | $7.5M |
| Q4 25 | $9.4M | $-2.1M | ||
| Q3 25 | $3.0M | $-883.8K | ||
| Q2 25 | $2.8M | $-1.8M | ||
| Q1 25 | $1.6M | $-1.2M | ||
| Q4 24 | $2.9M | $-2.2M | ||
| Q3 24 | $1.6M | $-1.2M | ||
| Q2 24 | $2.2M | $-494.3K | ||
| Q1 24 | $2.2M | $-1.3M |
| Q4 25 | 68.5% | 35.3% | ||
| Q3 25 | 63.6% | 32.6% | ||
| Q2 25 | 57.8% | 36.4% | ||
| Q1 25 | 50.8% | 30.7% | ||
| Q4 24 | 53.3% | 32.2% | ||
| Q3 24 | 48.7% | 34.0% | ||
| Q2 24 | 50.2% | 25.3% | ||
| Q1 24 | 48.1% | 31.2% |
| Q4 25 | 62.4% | -20.9% | ||
| Q3 25 | 23.4% | -11.5% | ||
| Q2 25 | 26.6% | -21.8% | ||
| Q1 25 | 19.3% | -14.6% | ||
| Q4 24 | 36.2% | -21.7% | ||
| Q3 24 | 23.4% | -13.1% | ||
| Q2 24 | 34.2% | -13.6% | ||
| Q1 24 | 36.3% | -17.9% |
| Q4 25 | 64.3% | -25.0% | ||
| Q3 25 | 26.8% | -9.4% | ||
| Q2 25 | 29.2% | -18.8% | ||
| Q1 25 | 22.1% | -13.3% | ||
| Q4 24 | 38.5% | -22.5% | ||
| Q3 24 | 25.8% | -14.2% | ||
| Q2 24 | 35.2% | -5.3% | ||
| Q1 24 | 36.8% | -17.0% |
| Q4 25 | $0.62 | — | ||
| Q3 25 | $0.20 | $-0.54 | ||
| Q2 25 | $0.20 | $-0.82 | ||
| Q1 25 | $0.12 | $-0.44 | ||
| Q4 24 | $0.21 | $49.77 | ||
| Q3 24 | $0.12 | $-11.61 | ||
| Q2 24 | $0.17 | $-43.48 | ||
| Q1 24 | $0.17 | $-2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $2.3M | — |
| Stockholders' EquityBook value | $108.2M | $23.0M |
| Total Assets | $116.2M | $30.1M |
| Debt / EquityLower = less leverage | 0.02× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $6.3M | — | ||
| Q1 24 | $5.3M | — |
| Q4 25 | $2.3M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $3.3M | — |
| Q4 25 | $108.2M | $23.0M | ||
| Q3 25 | $74.3M | $24.2M | ||
| Q2 25 | $49.3M | $25.7M | ||
| Q1 25 | $39.8M | $22.7M | ||
| Q4 24 | $37.7M | $23.5M | ||
| Q3 24 | $33.1M | $25.0M | ||
| Q2 24 | $25.4M | $23.5M | ||
| Q1 24 | $21.6M | $24.8M |
| Q4 25 | $116.2M | $30.1M | ||
| Q3 25 | $83.1M | $31.5M | ||
| Q2 25 | $57.7M | $32.0M | ||
| Q1 25 | $48.1M | $29.2M | ||
| Q4 24 | $44.0M | $30.6M | ||
| Q3 24 | $40.8M | $30.1M | ||
| Q2 24 | $32.2M | $29.3M | ||
| Q1 24 | $28.7M | $31.9M |
| Q4 25 | 0.02× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.15× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.7M | $-1.6M |
| Free Cash FlowOCF − Capex | $8.2M | $-1.6M |
| FCF MarginFCF / Revenue | 56.0% | -18.9% |
| Capex IntensityCapex / Revenue | 17.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.15× | — |
| TTM Free Cash FlowTrailing 4 quarters | $12.4M | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.7M | $-1.6M | ||
| Q3 25 | $2.4M | $-727.8K | ||
| Q2 25 | $3.5M | $-1.3M | ||
| Q1 25 | $2.4M | $-1.7M | ||
| Q4 24 | $3.2M | $-3.4M | ||
| Q3 24 | $2.5M | $-1.4M | ||
| Q2 24 | $2.6M | $-4.6M | ||
| Q1 24 | $2.6M | $-3.2M |
| Q4 25 | $8.2M | $-1.6M | ||
| Q3 25 | $709.8K | $-735.8K | ||
| Q2 25 | $2.5M | $-1.4M | ||
| Q1 25 | $1.0M | $-1.7M | ||
| Q4 24 | $2.1M | $-3.5M | ||
| Q3 24 | $1.9M | $-1.9M | ||
| Q2 24 | $2.4M | $-5.6M | ||
| Q1 24 | $2.3M | $-3.2M |
| Q4 25 | 56.0% | -18.9% | ||
| Q3 25 | 6.4% | -7.8% | ||
| Q2 25 | 26.5% | -15.2% | ||
| Q1 25 | 13.8% | -19.3% | ||
| Q4 24 | 28.0% | -36.6% | ||
| Q3 24 | 30.4% | -22.2% | ||
| Q2 24 | 38.7% | -59.7% | ||
| Q1 24 | 38.3% | -43.1% |
| Q4 25 | 17.7% | 0.0% | ||
| Q3 25 | 15.3% | 0.1% | ||
| Q2 25 | 10.8% | 1.7% | ||
| Q1 25 | 19.4% | 0.1% | ||
| Q4 24 | 13.6% | 1.1% | ||
| Q3 24 | 9.8% | 6.1% | ||
| Q2 24 | 4.3% | 10.5% | ||
| Q1 24 | 5.5% | 0.8% |
| Q4 25 | 1.15× | — | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 1.28× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.08× | — | ||
| Q3 24 | 1.56× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 1.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
